Therapeutic Goods Amendment Act 1997

Administered by Department of Health, Disability and Ageing

Legislation au C2004A05211 Not in force Act

Legislation content

 

 

 

 

Therapeutic Goods Amendment Act 1997

 

No. 116, 1997

 

 

 

 

An Act to amend the Therapeutic Goods Act 1989 to make provision relating to the listing of therapeutic goods and the supply of therapeutic goods not conforming to standards and to give effect to Australia’s obligations regarding therapeutic goods under an Agreement on Mutual Recognition with the European Community

 

Contents

1 Short title..................................2

2 Commencement..............................2

3 Schedule(s).................................2

Schedule 1—Amendment of the Therapeutic Goods Act 1989 3

Part 1—Therapeutic goods not conforming to standards 3

Part 2—Amendments relating to the Agreement on Mutual Recognition in relation to Conformity Assessment, Certificates and Markings between Australia and the European Community              5

Part 3—Other amendments 10

 

Therapeutic Goods Amendment Act 1997

No. 116, 1997

 

 

 

An Act to amend the Therapeutic Goods Act 1989 to make provision relating to the listing of therapeutic goods and the supply of therapeutic goods not conforming to standards and to give effect to Australia’s obligations regarding therapeutic goods under an Agreement on Mutual Recognition with the European Community

[Assented to 7 July 1997]

The Parliament of Australia enacts:

1  Short title

  This Act may be cited as the Therapeutic Goods Amendment Act 1997.

2  Commencement

 (1) Subject to subsection (2), this Act commences on the day on which it receives the Royal Assent.

 (2) Part 2 of Schedule 1 commences on a day to be fixed by Proclamation. That day must not be earlier than the day on which the Agreement on Mutual Recognition in relation to Conformity Assessment, Certificates and Markings between Australia and the European Community enters into force.

 (3) If Part 2 of Schedule 1 does not commence under subsection (2) within the period of 6 months after the day on which the Agreement referred to in that subsection enters into force, that Part commences on the first day after the end of that period.

3  Schedule(s)

  Subject to section 2, each Act that is specified in a Schedule to this Act is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this Act has effect according to its terms.


Schedule 1—Amendment of the Therapeutic Goods Act 1989

Part 1—Therapeutic goods not conforming to standards

1  At the end of Division 2 of Part 3

Add:

30B  Recovery etc. of registered or listed goods not conforming to standards

 (1) This section applies if:

 (a) therapeutic goods of a particular kind are included in the Register in relation to a person; and

 (b) any person supplies a batch of goods of that kind; and

 (c) the Secretary is satisfied that the goods included in that batch do not conform to a standard applicable to goods of that kind; and

 (d) the Secretary is not aware that any other goods of that kind supplied by the person within the previous 6 months have failed to conform to that standard or another standard applicable to goods of that kind.

 (2) The Secretary may, in writing, impose on the sponsor of the goods one or both of the following requirements:

 (a) to inform the public or a specified class of persons, in the specified manner and within such reasonable period as is specified, that the goods included in that batch do not conform to a standard applicable to goods of that kind;

 (b) to take steps to recover the goods included in that batch (except any of those goods that cannot be recovered because they have been administered to, or applied in the treatment of, a person or animal).

 (3) The Secretary must cause to be published in the Gazette, as soon as practicable after imposing such a requirement, a notice setting out particulars of the requirement.

 (4) A person who intentionally refuses or fails to comply with a requirement under subsection (2) is guilty of an offence.

Maximum penalty: 60 penalty units.

 (5) This section does not prevent the Secretary from taking action under section 30.


Part 2—Amendments relating to the Agreement on Mutual Recognition in relation to Conformity Assessment, Certificates and Markings between Australia and the European Community

2  Subsection 3(1)

Insert:

approved conformity assessment body means a conformity assessment body approved by the Secretary in writing.

3  Subsection 3(1)

Insert:

conformity assessment body means a Conformity Assessment Body designated in one of the following Sectoral Annexes to the Mutual Recognition Agreement:

 (a) Sectoral Annex (Medical Devices);

 (b) Sectoral Annex (Medicinal Products GMP Inspection and Batch Certification).

4  Subsection 3(1)

Insert:

conformity assessment certificate means an attestation of conformity (within the meaning of the Mutual Recognition Agreement) issued by an approved conformity assessment body.

5  Subsection 3(1)

Insert:

member of the European Community means a country declared by the Minister under section 3A to be a member of the European Community.

6  Subsection 3(1)

Insert:

Mutual Recognition Agreement means the Agreement on Mutual Recognition in relation to Conformity Assessment, Certificates and Markings between Australia and the European Community, as in force from time to time.

7  After section 3

Insert:

3A  Declaration—member of European Community

 (1) The Minister may declare, in writing, that a country specified in the declaration is a member of the European Community.

 (2) A declaration under subsection (1) must be published in the Gazette.

8  Paragraph 25(2)(a)

Repeal the paragraph, substitute:

 (a) whether the applicant has provided:

 (i) if the goods are not therapeutic devices and a step in the manufacture of the goods has been carried out in a country that is a member of the European Community—a conformity assessment certificate in relation to the goods; or

 (ii) in any other case—an acceptable form of evidence from a relevant overseas authority establishing that the manufacture of the goods is of an acceptable standard; and

9  After section 25

Insert:

25A  Registration of therapeutic device to which conformity assessment certificate applies

 (1) If:

 (a) an application is made in accordance with section 23 for the registration of a therapeutic device in relation to a person; and

 (b) the applicant gives to the Secretary a conformity assessment certificate as to the matters that would require evaluation under subsection 25(1) if that subsection applied in relation to the device;

the Secretary must register the device unless the Secretary considers that the device may compromise the health or safety of users.

 (2) The Secretary must notify the applicant in writing of his or her decision on the application within 28 days of the making of the decision. If the Secretary decides not to register the device, the notice must contain the reasons for that decision.

 (3) If the Secretary decides to register the device, the Secretary must:

 (a) include the device in the Register; and

 (b) give to the applicant a certificate of registration.

 (4) The registration of the device commences on the day specified for the purpose in the certificate of registration.

10  Subsection 26(1)

Before “the Secretary” (second occurring), insert “then, subject to section 26AA,”.

11  Paragraph 26(2)(a)

Repeal the paragraph, substitute:

 (a) whether the applicant has provided:

 (i) if the goods are not therapeutic devices and a step in the manufacture of the goods has been carried out in a country that is a member of the European Community—a conformity assessment certificate in relation to the goods; or

 (ii) in any other case—an acceptable form of evidence from a relevant overseas authority establishing that the manufacture of the goods is of an acceptable standard; and

12  After section 26

Insert:

26AA  Listing of therapeutic device to which conformity assessment certificate applies

 (1) If:

 (a) an application is made in accordance with section 23 for the listing of a therapeutic device in relation to a person; and

 (b) the applicant gives to the Secretary a conformity assessment certificate as to the matters specified in paragraphs 26(1)(c) to (m) in relation to the device;

the Secretary must list the device in relation to the person unless the Secretary considers that the device may compromise the health or safety of users.

 (2) The Secretary must notify the applicant in writing of his or her decision within 28 days of the making of the decision. If the Secretary decides not to list the device, the notice must contain the reasons for that decision.

 (3) If the Secretary decides to list the device, the Secretary must:

 (a) include the device in the Register; and

 (b) give to the applicant a certificate of listing.

 (4) The listing of the device commences on the day specified for the purpose in the certificate of listing.

13  Paragraph 26A(4)(a)

Repeal the paragraph, substitute:

 (a) whether the applicant has provided:

 (i) if the goods are not therapeutic devices and a step in the manufacture of the goods has been carried out in a country that is a member of the European Community—a conformity assessment certificate in relation to the goods; or

 (ii) in any other case—an acceptable form of evidence from a relevant overseas authority establishing that the manufacture of the goods is of an acceptable standard; and

14  Subsection 61(1) (at the end of the definition of therapeutic goods information)

Add “(including functions relating to the Mutual Recognition Agreement)”.


Part 3—Other amendments

15  Paragraph 26A(2)(c)

Omit “acceptable”, substitute “not unacceptable”.

 

 

[Minister’s second reading speech made in—

Senate on 26 March 1997

House of Representatives on 25 June 1997]

 

(48/97)


 

Overview

The Therapeutic Goods Amendment Act 1997 (Cth) was enacted by the Parliament of Australia to address the need for amendments to the Therapeutic Goods Act 1989, specifically concerning the listing of therapeutic goods and the supply of goods that do not meet certain standards. This Act also aims to give effect to Australia's obligations under the Agreement on Mutual Recognition in relation to Conformity Assessment, Certificates and Markings between Australia and the European Community. The primary policy objective of the Act is to enhance the regulatory framework for therapeutic goods by introducing measures to ensure conformity to standards and facilitating mutual recognition with the European Community. The Act provides mechanisms for the recovery of non-conforming goods and the imposition of public notification requirements for breaches of standards, aiming to safeguard public health and safety. The Therapeutic Goods Amendment Act 1997 introduces several amendments to the Therapeutic Goods Act 1989, including provisions for the registration and listing of therapeutic devices supported by conformity assessment certificates issued by approved bodies. This legislative change is designed to streamline the approval process for therapeutic goods manufactured in or involving members of the European Community, thereby fostering trade and cooperation in the therapeutic goods sector. Additionally, the Act outlines penalties for non-compliance with the imposed requirements, reinforcing the importance of adhering to the specified standards and regulatory obligations.

Scope and Application

The Therapeutic Goods Amendment Act 1997 is a Commonwealth Act that amends the Therapeutic Goods Act 1989. The Act applies to individuals and entities involved in the supply of therapeutic goods, which are products that are intended to diagnose, treat, mitigate, or prevent a disease, ailment, defect, or injury in humans or animals. It also applies to the listing of therapeutic goods in the Australian Register of Therapeutic Goods (ARTG) and the conformity of these goods with applicable standards. The Act has a national jurisdictional reach as it is a Commonwealth Act. The Act does not explicitly state any exclusions, exemptions, or thresholds, but it does provide provisions for the registration and listing of therapeutic goods that conform to standards, including the acceptance of conformity assessment certificates issued by approved conformity assessment bodies in the European Community under the Agreement on Mutual Recognition. The Act can extend its application through subordinate instruments such as regulations and guidelines.

Key Provisions

The Therapeutic Goods Amendment Act 1997 primarily amends the Therapeutic Goods Act 1989 to address the listing of therapeutic goods and the supply of goods that do not meet required standards. It also aligns Australia's regulatory framework with the European Community under an Agreement on Mutual Recognition. The Act introduces several key sections. Section 30B, for instance, allows the Secretary to require a sponsor to inform the public if goods do not conform to applicable standards, and to take steps to recover such goods, except those already administered to or applied in the treatment of a person or animal. Failure to comply with these requirements is an offence, with a maximum penalty of 60 penalty units. The Act imposes several obligations on parties involved in the supply and listing of therapeutic goods. For example, it mandates that any person supplying therapeutic goods must ensure they conform to the relevant standards. If goods do not meet these standards, the Secretary can impose specific corrective actions as mentioned above. Additionally, under the Mutual Recognition Agreement provisions, sponsors must provide a conformity assessment certificate if a step in the manufacture of the goods was carried out in a member country of the European Community. In cases where the goods were not manufactured in a member country, they must provide acceptable evidence from a relevant overseas authority. Breaches of the Act can result in significant consequences. The most notable is the imposition of fines for non-compliance with the Secretary's requirements regarding the recovery and public notification of non-conforming goods. Under section 30B(4), a person who intentionally refuses or fails to comply with these requirements commits an offence and faces a maximum penalty of 60 penalty units. This penalty underscores the importance of adhering to the Act's provisions to avoid legal repercussions.

Legal classification tags

Area of Law
Medical Law
Instrument
Act
Concepts
Commencement Provisions
Offence Provisions
Compliance Obligations
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.